Article: Applied Biosystems and the Rutgers Stem Cell Research Center to Host New Jersey Stem Cell Technology Symposium.

BRIDGEWATER, N.J. -- Applied Biosystems (NYSE:ABI), an Applera Corporation business, and the Rutgers Stem Cell Research Center today announced that they will hold the first New Jersey Stem Cell Technology Symposium this week. The purpose of the symposium is to bring together scientists working on stem cell research in both academia and industry to discuss best practices and drive standardization to advance science and enable greater collaboration.

Stem cells offer great potential to develop new therapies for cancer, diabetes, spinal cord injury, and degenerative diseases of the nervous system, such as Parkinson's disease. Because it is a relatively new field, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!